U.S. federal trademark · Serial No. 88981892 · Reg. No. 6442600
Pharmaceutical preparations, containing tasimelteon, for use in the treatment of circadian rhythm diseases and disorders; pharmaceutical preparations, containing tasimelteon, for use in the treatment of non-24 hour sleep-wake disorder; and pharmaceutical preparations containing tasimelteon for use in the treatment of circadian rhythm sleep disorders; pharmaceutical preparations containing tasimelteon for use in the treatment of Smith-Magenis Syndrome
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.